BioXcel Therapeutics, Inc. (BTAI) has a market capitalization of $28.43M and trades at $1.05. The 52-week range is 1.08-8.08.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.2, Earnings Per Share (EPS) of $-5.73, annual revenue of $642K.
The stock has a beta of 0.30, operates in the Healthcare sector.
